Express Scripts Wants Class Bid Cut In Acthar Case
By Celeste Bott · November 14, 2023, 7:58 PM EST
Express Scripts and its subsidiaries asked an Illinois federal judge Monday not to certify a class of customers bringing antitrust allegations over sales of the anti-seizure drug Acthar, saying it doesn't...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login